Furthermore, single nucleotide polymorphisms (SNPs) of NLRP3 are associated with Crohn’s disease, a risk factor for CRC, and a gain-of-function mutation results in poorer survival of patients suffering from CRC and increases the risk of developing melanoma [58,59]. This evidence concerns the gene NLRP3 and colorectal carcinoma.